• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period.

作者信息

Kindel Tammy L, Wang Andrew Y, Wadhwa Anupama, Schulman Allison R, Sharaiha Reem Z, Kroh Matthew, Ghanem Omar M, Levy Shauna, Joshi Girish P, LaMasters Teresa L

机构信息

Department of Surgery, Medical College of Wisconsin, Milwaukee, Wisconsin.

Division of Gastroenterology and Hepatology, University of Virginia, Charlottesville, Virginia.

出版信息

Surg Obes Relat Dis. 2024 Dec;20(12):1183-1186. doi: 10.1016/j.soard.2024.08.033. Epub 2024 Oct 29.

DOI:10.1016/j.soard.2024.08.033
PMID:39482213
Abstract
摘要

相似文献

1
Multisociety clinical practice guidance for the safe use of glucagon-like peptide-1 receptor agonists in the perioperative period.围手术期安全使用胰高血糖素样肽-1受体激动剂的多学会临床实践指南。
Surg Obes Relat Dis. 2024 Dec;20(12):1183-1186. doi: 10.1016/j.soard.2024.08.033. Epub 2024 Oct 29.
2
Multisociety Clinical Practice Guidance for the Safe Use of Glucagon-like Peptide-1 Receptor Agonists in the Perioperative Period.围手术期安全使用胰高血糖素样肽-1受体激动剂的多学会临床实践指南。
Clin Gastroenterol Hepatol. 2024 Oct 29. doi: 10.1016/j.cgh.2024.10.003.
3
Letter to the editor regarding multisociety clinical practice guidance - safe use of glucagon-like peptide-1 receptor agonists in perioperative period.致编辑的信：关于多学会临床实践指南——胰高血糖素样肽-1受体激动剂在围手术期的安全使用
Surg Obes Relat Dis. 2025 Jun;21(6):695-696. doi: 10.1016/j.soard.2024.12.014. Epub 2024 Dec 21.
4
Glucagon-like peptide-1 receptor agonists: a narrative review of clinical pharmacology and implications for peri-operative practice.胰高血糖素样肽-1 受体激动剂：临床药理学的叙述性综述及其对围手术期实践的影响。
Anaesthesia. 2024 Jul;79(7):735-747. doi: 10.1111/anae.16306. Epub 2024 May 13.
5
Response to Milder et al. "Letter to the editor regarding multisociety clinical practice guidance- safe use of glucagon-like peptide-1 receptor agonists in perioperative period".对米尔德尔等人《致编辑的信：关于多学会临床实践指南——胰高血糖素样肽-1受体激动剂在围手术期的安全使用》的回应
Surg Obes Relat Dis. 2025 Jun;21(6):696. doi: 10.1016/j.soard.2025.01.012. Epub 2025 Feb 14.
6
Comparison of societal guidance on perioperative management of glucagon-like peptide-1 receptor agonists: implications for clinical practice and future investigations.比较胰高血糖素样肽-1 受体激动剂围手术期管理的社会指导：对临床实践和未来研究的影响。
Can J Anaesth. 2024 Sep;71(9):1302-1315. doi: 10.1007/s12630-024-02810-5. Epub 2024 Aug 26.
7
Is it necessary to stop glucagon-like peptide-1 receptor agonists prior to endoscopic procedure? A retrospective study.在内镜检查前停用胰高血糖素样肽-1受体激动剂有必要吗？一项回顾性研究。
World J Gastroenterol. 2024 Jul 14;30(26):3221-3228. doi: 10.3748/wjg.v30.i26.3221.
8
Perioperative management of long-acting glucagon-like peptide-1 (GLP-1) receptor agonists: concerns for delayed gastric emptying and pulmonary aspiration.长效胰高血糖素样肽-1（GLP-1）受体激动剂的围手术期管理：关注胃排空延迟和肺吸入的问题。
Br J Anaesth. 2024 Apr;132(4):644-648. doi: 10.1016/j.bja.2024.01.001. Epub 2024 Jan 29.
9
Association between glucagon-like peptide-1 receptor agonist use and peri-operative pulmonary aspiration: a systematic review and meta-analysis.胰高血糖素样肽-1受体激动剂的使用与围手术期肺误吸之间的关联：一项系统评价和荟萃分析。
Anaesthesia. 2025 Jul;80(7):846-858. doi: 10.1111/anae.16601. Epub 2025 Apr 15.
10
Glucagon-Like Peptide-1 Receptor Agonists in the Peri-Operative Period.围手术期胰高血糖素样肽-1受体激动剂
Br J Hosp Med (Lond). 2025 Jan 24;86(1):1-4. doi: 10.12968/hmed.2024.0566. Epub 2025 Jan 9.

引用本文的文献

1
Glucagon-Like Peptide-1 Receptor Agonists and Peri-Procedural Aspiration Risk.胰高血糖素样肽-1受体激动剂与围手术期误吸风险
J Endocr Soc. 2025 Jul 10;9(9):bvaf088. doi: 10.1210/jendso/bvaf088. eCollection 2025 Sep.
2
Pulse Oximetry Desaturation in the Postoperative Recovery Room in Patients with Obesity and Diabetes Using GLP-1 Agonists: A Retrospective Observational Study.使用胰高血糖素样肽-1激动剂的肥胖和糖尿病患者术后恢复室中的脉搏血氧饱和度降低：一项回顾性观察研究
Cureus. 2025 Jul 12;17(7):e87774. doi: 10.7759/cureus.87774. eCollection 2025 Jul.
3
The role of GLP-1 agonists in perioperative care: a suspension dilemma.
胰高血糖素样肽-1激动剂在围手术期护理中的作用：一个悬而未决的难题。
Braz J Anesthesiol. 2025 Aug 5;75(5):844668. doi: 10.1016/j.bjane.2025.844668.
4
Implications of GLP-1 Agonists on Office-Based Sedation and General Anesthesia for Dentistry.胰高血糖素样肽-1激动剂对牙科门诊镇静和全身麻醉的影响。
Anesth Prog. 2025 Mar 12;72(1):52-58. doi: 10.2344/anpr-72-1-ANPR_Agonists.
5
Beyond Blood Sugar: A Scoping Review of GLP-1 Receptor Agonists in Cardiovascular Care.血糖之外：胰高血糖素样肽-1受体激动剂在心血管护理中的范围综述
Cardiol Ther. 2025 Jul 11. doi: 10.1007/s40119-025-00426-4.
6
Preoperative optimization of obese spine patients with GLP-1 receptor agonists: enhancing surgery and improving outcomes.使用胰高血糖素样肽-1受体激动剂对肥胖脊柱患者进行术前优化：增强手术效果并改善预后。
J Spine Surg. 2025 Jun 27;11(2):339-346. doi: 10.21037/jss-24-152. Epub 2025 Apr 14.
7
Semaglutide: a key medication for managing cardiovascular-kidney-metabolic syndrome.司美格鲁肽：治疗心血管-肾脏-代谢综合征的关键药物。
Future Cardiol. 2025 Jul;21(9):663-683. doi: 10.1080/14796678.2025.2511412. Epub 2025 Jun 3.
8
Risk of aspiration during general anaesthesia in patients on glucagon-like peptide-1 (GLP-1) receptor agonists: implications for patients on the kidney transplant waiting list.使用胰高血糖素样肽-1（GLP-1）受体激动剂的患者在全身麻醉期间发生误吸的风险：对等待肾移植的患者的影响。
Clin Kidney J. 2025 Apr 15;18(5):sfaf110. doi: 10.1093/ckj/sfaf110. eCollection 2025 May.
9
The Impact of Glucagon-Like Peptide-1 Receptor Agonists on Pharmacokinetics and Toxicokinetics: Is a New Diagnostic and Therapeutic Framework Needed?胰高血糖素样肽-1受体激动剂对药代动力学和毒代动力学的影响：是否需要一个新的诊断和治疗框架？
J Med Toxicol. 2025 Jul;21(3):301-303. doi: 10.1007/s13181-025-01075-8. Epub 2025 Apr 11.
10
Weight Reduction with GLP-1 Agonists and Paths for Discontinuation While Maintaining Weight Loss.使用胰高血糖素样肽-1（GLP-1）激动剂减重及维持体重减轻的停药途径。
Biomolecules. 2025 Mar 13;15(3):408. doi: 10.3390/biom15030408.